A phase II trial of m-AMSA in head and neck cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (6)
The experimental antitumour properties of three congeners of the acridylmethanesulphonanilide (AMSA) series
1974 • 155 citations
Phase 1 clinical investigation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992), a new acridine derivative.
1978 • 71 citations
Phase I study of methanesulfonamide, N-[4-(9-acridinylamino)-3-methoxyphenyl]-(m-AMSA) using a single-dose schedule.
1978 • 41 citations
Phase II study of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in metastatic breast cancer.
1979 • 21 citations
Phase I evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) by a weekly iv dose schedule.
1980 • 9 citations
Phase II. Evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced sarcoma.
1980 • 8 citations